JACOBS LEVY EQUITY MANAGEMENT, INC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$98,000
-89.6%
36,500
-88.5%
0.00%
-92.9%
Q1 2019$939,000
+120.4%
317,095
+18.5%
0.01%
+100.0%
Q4 2018$426,000
-49.9%
267,613
+15.8%
0.01%
-41.7%
Q3 2018$850,000
+40.5%
231,113
+8.1%
0.01%
+20.0%
Q2 2018$605,000
+7.7%
213,813
+41.2%
0.01%
+11.1%
Q1 2018$562,000
+25.2%
151,400
-2.9%
0.01%
+12.5%
Q4 2017$449,000155,9000.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders